ARCH Venture Partners XII, LLC - Insider Trading & Ownership

Entity
Company
Location
8755 W Higgins Road, Suite 1025, Chicago, IL
Summary
The estimated value of insider holdings of ARCH Venture Partners XII, LLC is at least $479M dollars as of June 10, 2024. ARCH Venture Partners XII, LLC is the 10%+ Owner of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $383M. ARCH Venture Partners XII, LLC is the 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $96.6M.
All Insider Reports
All Insider Reports

Ownership of ARCH Venture Partners XII, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NMRA Neumora Therapeutics, Inc. 10%+ Owner $383M +$5.93M +1.57% Dec 8, 2023
PRME Prime Medicine, Inc. 10%+ Owner $96.6M +$20M +26.1% Feb 15, 2024
RAPP Rapport Therapeutics, Inc. 10%+ Owner Jun 10, 2024

Insider Transactions Reported by ARCH Venture Partners XII, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.